Hungary issued initial approval for two additional COVID-19 vaccines that were not authorized by the European pharmaceutical regulator, country officials said on Monday.
The Hungarian Pharmaceutical Regulatory Authority has urgent approval for Convidecia, developed by the Chinese company CanSino Biologics and Covishield, developed by the Serum Institute of India, Medical Director Cecilia Muller informed at a Online press conference.
“We are confident with this increase in range [of vaccines]”We can also increase their numbers and give the population the widest possible vaccination opportunity possible,” Muller said.
Citing Coronavirus’s third batch, Muller said that the vaccine marks “the only way out of a pandemic”, adding that Hungary will continue to seek vaccine sources from around the world. .
The move brings the number of vaccines authorized in Hungary to seven, as the country has agreed to vaccines developed by Pfizer / BioNTech, Moderna, University of AstraZeneca / Oxford, Sinopharm of China. , as well as the Russian vaccine Sputnik V.